Biopharmaceutical Informatics
Biopharmaceutical informatics combines a knowledge-based informatics approach (database creation, curation, mining, etc.) with physics-based molecular modeling and simulation tools (derived from computational biophysics) for biopharmaceuticals. It is an interdisciplinary field that supports the development of. As with many new areas of science and technology, it is too early to provide an accurate definition of biopharmaceutical informatics. Biopharmacy informatics is a computational task, either alone or in combination with experimental studies, aimed at facilitating efficient and cost-effective translation of biopharmacy candidates into drugs. This article describes calculations focused on predicting the site of chemical degradation of biopharmaceutical candidates. In particular, case studies will be used to discuss those involved in methionine oxidation, lysine saccharification, asparagine deamidation, and aspartic acid isomerization. However, computational modeling applications extend to assessing other aspects of the feasibility of biological agents, such as the development of biological agents (see the various chapters of Kumar and Singh's Book 4). These techniques can be extended to late product development and lifecycle management of biopharmaceuticals already on the market. Business development is another potential application of biopharmacy informatics, enabling feasibility risk assessments to be integrated into the decision-making process for introducing biopharmaceutical candidates for development. Therefore, biopharmacy informatics can be applied organically at all stages of biopharmaceutical discovery and development whenever knowledge of molecular properties is required.
Related Conference of Biopharmaceutical Informatics
25th International Conference on Drug Discovery, Design and Development
Biopharmaceutical Informatics Conference Speakers
Recommended Sessions
- Advanced Drug Delivery System
- BCS and IVIVC Based Biowaivers
- Biological Medicine
- Biopharmaceutical Informatics
- Chemical and Analytical Strategies for Biosimilars
- Consequences of Brexit on Biosimilars
- Digital Pharma
- Drug Delivery Technology
- Drug Formulation
- Encapsulated Drugs
- Intellectual Property Rights
- Pharmaceutical Chemistry
- Pharmaceutical Manufacturing
- Pharmacogenomics
Related Journals
Are you interested in
- Biomedical Diagnosis - Biomedicine 2023 (Canada)
- Biomedical model - Biomedicine 2023 (Canada)
- Biomedical Science - Biomedicine 2023 (Canada)
- Biomedical statistics - Biomedicine 2023 (Canada)
- Biomedicine - Biomedicine 2023 (Canada)
- Biopharmaceutical - Biomedicine 2023 (Canada)
- Clinical and Medical Toxicology - Pharma Forum 2023 (France)
- Clinical Pharmacology and Receptor Therapy - Pharma Forum 2023 (France)
- Clinical Therapeutics - Pharma Forum 2023 (France)
- Cognitive Behaviour Therapy and Holistic Therapy - Pharma Forum 2023 (France)
- Computational Biomedicine - Biomedicine 2023 (Canada)
- Frontiers in Biomedicine - Biomedicine 2023 (Canada)
- Immunopharmacology - Biomedicine 2023 (Canada)
- Industrial pharmacy - Biomedicine 2023 (Canada)
- Medical devices - Biomedicine 2023 (Canada)
- Molecular biomedicine - Biomedicine 2023 (Canada)
- Nanotechnology - Biomedicine 2023 (Canada)
- Personalized medicine - Biomedicine 2023 (Canada)
- Pharmaceutical Technology - Biomedicine 2023 (Canada)
- Pharmacognosy - Biomedicine 2023 (Canada)
- Pharmacological sciences - Biomedicine 2023 (Canada)
- Pharmacology - Pharma Forum 2023 (France)
- Pharmacology and Drug Design - Pharma Forum 2023 (France)
- Pharmacotherapy - Biomedicine 2023 (Canada)
- Pharmacotoxicology - Pharma Forum 2023 (France)
- Toxicology - Pharma Forum 2023 (France)